Profiling the oral microbiomes in patients with Alzheimer's disease
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Alzheimer's disease [X]Dementia in Alzheimer's disease,[X]Dementia in Alzheimer's disease (disorder),AD,AD - Alzheimer's disease,Alzheimer Dementia,Alzheimer dementia,Alzheimer Dementia, Presenile,ALZHEIMER DIS,Alzheimer Disease,Alzheimer disease,Alzheimer disease, familial,Alzheimer Type Dementia,Alzheimer's,Alzheimer's Dementia,Alzheimer's dementia,Alzheimer's disease,Alzheimer's disease (disorder),Alzheimer's disease, NOS,Alzheimers,Alzheimers Dementia,Alzheimers dementia,ALZHEIMERS DIS,Alzheimers disease,DAT - Dementia Alzheimer's type,Dementia in Alzheimer's disease,Dementia in Alzheimer's disease (disorder),Dementia in Alzheimer's disease, unspecified (disorder),Dementia of the Alzheimer's type,Dementia, Alzheimer Type,Dementia, Presenile,Dementia, Presenile Alzheimer,Disease, Alzheimer,Disease, Alzheimer's,Presenile Alzheimer Dementia,sporadic Alzheimer's disease,alzheimer's disease
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Cognitive intact subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Alzheimer's Disease (AD) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Alzheimer's Disease
- Group 0 sample size Number of subjects in the control (unexposed) group
- 26
- Group 1 sample size Number of subjects in the case (exposed) group
- 26
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 3 months
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- PacBio RS
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Metastats
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Signature 1
Source: Figure 3a
Description: Differential salivary microbes in AD patients and cognitive-intact subjects
Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Deinococcota |
Revision editor(s): AaishahM
Signature 2
Source: Figure 3a
Description: Differential salivary microbes in AD patients and cognitive-intact subjects
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Fusobacteriia | ||
Pseudomonadota |
Revision editor(s): AaishahM
Experiment 2
Subjects
Lab analysis
Statistical Analysis
- Statistical test
- LEfSe
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2.0
Signature 1
Source: Figure 3b
Description: Differential salivary microbes in AD patients and cognitive-intact subjects
Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients
Revision editor(s): AaishahM
Signature 2
Source: Figure 3b
Description: Differential salivary microbes in AD patients and cognitive-intact subjects
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
Revision editor(s): AaishahM
Experiment 3
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Gingival groove Gingival sulcus,Sulcus gingivalis,Tooth-gingiva interface,Gingival groove,gingival groove
Lab analysis
Statistical Analysis
- Statistical test
- Metastats
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- Not specified
Signature 1
Source: Figure 4a
Description: Differential gingival crevicular fluid (GCF) microbes in AD patients and cognitive-intact subjects
Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Actinomycetota |
Revision editor(s): AaishahM
Signature 2
Source: Figure 4a
Description: Differential gingival crevicular fluid (GCF) microbes in AD patients and cognitive-intact subjects
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Pseudomonadota | ||
Fusobacteriia | ||
Mycoplasmatota | ||
Chloroflexia |
Revision editor(s): AaishahM
Experiment 4
Subjects
Lab analysis
Statistical Analysis
- Statistical test
- LEfSe
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2.0
Signature 1
Source: Figure 4b
Description: Differential gingival crevicular fluid (GCF) microbes in AD patients and cognitive-intact subjects
Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients
Revision editor(s): AaishahM
Signature 2
Source: Figure 4b
Description: Differential gingival crevicular fluid (GCF) microbes in AD patients and cognitive-intact subjects
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
Revision editor(s): AaishahM
Experiment 5
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Early-onset Alzheimer's Disease patients (EAS)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Late-onset Alzheimer's Disease patients (NAS)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with late-onset Alzheimer's Disease
- Group 0 sample size Number of subjects in the control (unexposed) group
- 10
- Group 1 sample size Number of subjects in the case (exposed) group
- 16
Lab analysis
Statistical Analysis
- Statistical test
- Welch's T-Test
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- Not specified
Signature 1
Source: Figure 5a
Description: Differential bacteria in AD patients with different clinical types
Abundance in Group 1: increased abundance in Late-onset Alzheimer's Disease patients (NAS)
NCBI | Quality Control | Links |
---|---|---|
Parvimonas micra | ||
Prevotella veroralis | ||
Segatella oris | ||
Streptococcus anginosus | ||
Veillonella parvula | ||
Ligilactobacillus salivarius |
Revision editor(s): AaishahM
Signature 2
Source: Figure 5a
Description: Differential bacteria in AD patients with different clinical types
Abundance in Group 1: decreased abundance in Late-onset Alzheimer's Disease patients (NAS)
NCBI | Quality Control | Links |
---|---|---|
Capnocytophaga leadbetteri | ||
Streptococcus cristatus | ||
Capnocytophaga granulosa | ||
Neisseria elongata | ||
Stomatobaculum longum |
Revision editor(s): AaishahM
Experiment 6
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Gingival groove Gingival sulcus,Sulcus gingivalis,Tooth-gingiva interface,Gingival groove,gingival groove
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Early-onset Alzheimer's Disease patients (EAG)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Late-onset Alzheimer's Disease patients (NAG)
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 5b
Description: Differential bacteria in AD patients with different clinical types
Abundance in Group 1: increased abundance in Late-onset Alzheimer's Disease patients (NAG)
NCBI | Quality Control | Links |
---|---|---|
Streptococcus constellatus | ||
Porphyromonas gingivalis | ||
Mogibacterium timidum |
Revision editor(s): AaishahM
Experiment 7
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Cognitive intact subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Alzheimer's Disease (AD) patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Alzheimer's Disease
- Group 0 sample size Number of subjects in the control (unexposed) group
- 26
- Group 1 sample size Number of subjects in the case (exposed) group
- 26
Lab analysis
Statistical Analysis
Signature 1
Source: Figure S2a
Description: Differential microbes in the saliva from AD patients and cognitive intact subjects
Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients
NCBI | Quality Control | Links |
---|---|---|
Veillonella parvula | ||
Stomatobaculum longum | ||
Veillonella dispar | ||
Prevotella denticola | ||
Ligilactobacillus salivarius | ||
Granulicatella adiacens | ||
Dialister invisus | ||
Gemella sanguinis |
Revision editor(s): AaishahM
Signature 2
Source: Figure S2a
Description: Differential microbes in the saliva from AD patients and cognitive intact subjects
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
Revision editor(s): AaishahM
Experiment 8
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Gingival groove Gingival sulcus,Sulcus gingivalis,Tooth-gingiva interface,Gingival groove,gingival groove
Lab analysis
Statistical Analysis
Signature 1
Source: Figure S2b
Description: Differential microbes in the gingival crevicular fluid (GCF) from AD patients and cognitive intact subjects
Abundance in Group 1: increased abundance in Alzheimer's Disease (AD) patients
Revision editor(s): AaishahM
Signature 2
Source: Figure S2b
Description: Differential microbes in the gingival crevicular fluid (GCF) from AD patients and cognitive intact subjects
Abundance in Group 1: decreased abundance in Alzheimer's Disease (AD) patients
Revision editor(s): AaishahM
Experiment 9
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Early-onset Alzheimer's Disease patients (EAS)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Late-onset Alzheimer's Disease patients (NAS)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with late-onset Alzheimer's Disease
- Group 0 sample size Number of subjects in the control (unexposed) group
- 10
- Group 1 sample size Number of subjects in the case (exposed) group
- 16
Signature 1
Source: Figure S3d
Description: Differential abundance of bacteria in AD patients with different clinical types
Abundance in Group 1: increased abundance in Late-onset Alzheimer's Disease patients (NAS)
NCBI | Quality Control | Links |
---|---|---|
Veillonella parvula | ||
Segatella oris |
Revision editor(s): AaishahM
Signature 2
Source: Figure S3d
Description: Differential abundance of bacteria in AD patients with different clinical types
Abundance in Group 1: decreased abundance in Late-onset Alzheimer's Disease patients (NAS)
Revision editor(s): AaishahM
Experiment 10
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Gingival groove Gingival sulcus,Sulcus gingivalis,Tooth-gingiva interface,Gingival groove,gingival groove
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Early-onset Alzheimer's Disease patients (EAG)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Late-onset Alzheimer's Disease patients (NAG)
Lab analysis
Statistical Analysis
Signature 1
Source: Figure S3e
Description: Differential abundance of bacteria in AD patients with different clinical types
Abundance in Group 1: increased abundance in Late-onset Alzheimer's Disease patients (NAG)
NCBI | Quality Control | Links |
---|---|---|
Porphyromonas gingivalis | ||
Streptococcus constellatus |
Revision editor(s): AaishahM
Signature 2
Source: Figure S3e
Description: Differential abundance of bacteria in AD patients with different clinical types
Abundance in Group 1: decreased abundance in Late-onset Alzheimer's Disease patients (NAG)
NCBI | Quality Control | Links |
---|---|---|
Rothia dentocariosa |
Revision editor(s): AaishahM